4SC AG (LTS:0R6U) Institutional Ownership: 0.28% (As of Sep. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0R6U 4SC AG LTS:0R6U
8 GF Score
Price €6.47
GF Value €226.96
! 7 Warning Signs
View Full Analysis

What is 4SC AG Institutional Ownership?

4SC AG LTS:0R6U 8 Institutional Ownership is 0.28% as of Sep. 02, 2026. GuruFocus rates LTS:0R6U with a GF Score™ of 8/100 and a GF Value™ of €226.96. The stock has 7 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, 4SC AG's institutional ownership is 0.28%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, 4SC AG's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, 4SC AG's Float Percentage Of Total Shares Outstanding is 0.00%.

4SC AG Institutional Ownership Historical Data

* Premium members only.

The historical data trend for 4SC AG's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4SC AG Institutional Ownership Chart

4SC AG Historical Data

The historical data trend for 4SC AG can be seen below:

2020-05-31 2020-06-30 2020-07-31 2020-08-31 2020-09-30 2020-10-31 2020-11-30 2020-12-31 2021-01-31 2021-02-28
Institutional Ownership 0.59 0.41 0.41 0.41 0.31 0.31 0.31 0.28 0.28 0.28
LTS:0R6U
8GF Score
4SC AG LTS:0R6U
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

4SC AG Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.28% mean?
4SC AG (LTS:0R6U) has a Institutional Ownership of 0.28% as of Sep. 02, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on 4SC AG and its competitors.
Is 4SC AG's Institutional Ownership too high?
4SC AG's current Institutional Ownership is 0.28%. Overall, 4SC AG has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does 4SC AG's Institutional Ownership compare to VRTX and REGN?
4SC AG's Institutional Ownership of 0.28% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on 4SC AG and its competitors. 4SC AG's current Institutional Ownership is 0.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4SC AG stock overvalued right now?
4SC AG (LTS:0R6U) has a current Institutional Ownership of 0.28%. The stock's GF Value™ is €226.96, compared to a current price of €6.47 — trading 97.2% below its estimated fair value. The current Institutional Ownership is 0.28%. 4SC AG's overall GF Score™ is 8/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For 4SC AG (LTS:0R6U), the current Institutional Ownership is 0.28% as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 4SC AG (LTS:0R6U) Overvalued in 2026?

Based on GuruFocus' analysis, 4SC AG stock appears to be undervalued. The current stock price of €6.47 is trading 97.2% below its estimated GF Value™ of €226.96.

Key valuation signals for LTS:0R6U:

  • Institutional Ownership: 0.28%
  • GF Value™: €226.96 vs. price of €6.47 (97.2% below fair value)
  • GF Score™: 8/100 with 7 warning signs

No single metric tells the full story. See the LTS:0R6U stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

4SC AG Business Description

Address Fraunhoferstrasse 22, Planegg-Martinsried, DEU, 82152
4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. The geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.
8GF Score

Get the complete analysis for LTS:0R6U

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.47
Price
€226.96
GF Value